NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.


Don't have an account? Subscribe

IBTS reviewing incident report process after HPRA inspection

By Catherine Reilly - 14th Mar 2022

The Health Products Regulatory Authority (HPRA) raised a major deficiency following an inspection of the Irish Blood Transfusion Service (IBTS) tissue bank, which related to the management of incident reports (IRs) within the quality system. 

This deficiency consisted of “a combination of eight minor incident report deficiencies which, when viewed together, were graded as a major deficiency”, an IBTS spokesperson told the Medical Independent (MI)

The matter was an item at the IBTS board meeting in November 2021. 

The spokesperson for the IBTS said responses for the eight minor incidents have been submitted to the HPRA. The response includes a commitment to complete a full review and update of the IR process and “formal implementation of the quality partnering initiative”, which is also an initiative in the IBTS’s strategic plan. 

“The ultimate aim of partnering by quality is to further develop relationships with the various business units in the organisation and work with those units as customers to ensure that the IBTS has a compliant, effective and efficient quality management system,” outlined the IBTS’s spokesperson. 

Meanwhile, the IBTS has appointed Prof Tor Hervig as its new Medical and Scientific Director. Prof Hervig graduated in medicine from the University of Bergen, Norway, in 1979. He undertook specialist training in immunology and transfusion medicine and worked as Head of Department and senior consultant at Stavanger University Hospital and Haukeland University Hospital, Norway. 

In 2007 he was appointed Professor in Transfusion Medicine at the University of Bergen. He has also worked in Tanzania and served on several national and international committees. His main interests include blood donor care, blood components, stem cell therapies and clinical transfusion practice. 

The IBTS confirmed to MI that Prof Hervig has relocated to Dublin to take on the role. 

Leave a Reply

Latest
Latest Issue
The Medical Independent 20th February
The Medical Independent 20th February 2024

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read